Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Intomics Enters €5.2M Personalized Cancer Diagnostic Project

Published: Thursday, June 06, 2013
Last Updated: Thursday, June 06, 2013
Bookmark and Share
Vejle Sygehus, DTU, Exiqon A/S, and Intomics A/S have joined forces.

The project will optimize treatment of cancer patients based on the cancers’ individual genetic fingerprint. Intomics will use its leading biomedical data analysis capabilities to help choose the right treatment from cancer-derived genetic information.

The project receives €3.0M in financial support from The Danish National Advanced Technology Foundation.

Two cancer patients may respond very differently to the same treatment if their genetic cancer fingerprints differ.

Mutations in genes participating in key cancer pathways and mechanisms may impact whether a given patient responds well to a treatment or not.

“By enhancing our understanding of the correlation between key mutations in cancer pathways and treatment outcome, we can better select the optimal treatment for each individual patient” says Thomas S. Jensen, CEO of Intomics A/S.

Vejle Sygehus, the Technical University of Denmark (DTU), Exiqon A/S, and Intomics A/S have joined forces to develop a future platform for precision medicine in a five-year project supported by The Danish National Advanced Technology Foundation.

The project will focus on colorectal cancer, where genetic information from many samples will be available.

Intomics A/S is developing sophisticated tools for analyzing and combining large quantities of biomedical data, including genetic variation data from individuals.

Based on these tools and Intomics’ unique expertise within molecular systems biology, genetic data derived from tumours will be analyzed and correlated with treatment outcome to advance the field of precision medicine.

Thomas S. Jensen continues, “We are very happy to be part of the project. I see a great synergy between the four partners and strongly believe that by teaming up with leading companies and research institutions in cancer research, data analysis, and diagnostic kit development, we can make important discoveries that can help cancer patients.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Common Cell Transformed into Master Heart Cell
By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin—Madison have generated master heart cells — primitive progenitors that form the developing heart.
Genetic Mutation that Prevents Diabetes Complications
The most significant complications of diabetes include diabetic retinal disease, or retinopathy, and diabetic kidney disease, or nephropathy. Both involve damaged capillaries.
Could the Food we Eat Affect Our Genes?
Almost all of our genes may be influenced by the food we eat, according to new research.
Neanderthal DNA Influences Human Disease Risk
Large-scale, evolutionary analysis compares genetic data alongside electronic health records.
Improving Regenerative Medicine
Lab-created stem cells may lack key characteristics, UCLA research finds.
Tick Genome Reveals Secrets of a Successful Bloodsucker
NIH has announced that decipher the genome of the blacklegged tick which could lead to new tick control methods.
"Dark Side" of the Transcriptome
New approach to quantifying gene "read-outs" reveals important variations in protein synthesis and has implications for understanding neurodegenerative diseases.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
New Source of Mutations in Cancer
Recently, a new mutation signature found in cancer cells was suspected to have been created by a family of enzymes found in human cells called the APOBEC3 family.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!